Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, May 28, 2020
Sino Biopharmaceutical Announces 2020 First Quarterly Results
Tuesday, May 26, 2020
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration
Tuesday, May 19, 2020
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
Monday, March 30, 2020
Sino Biopharm Announces 2019 Annual Results
Tuesday, January 21, 2020
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
Tuesday, November 26, 2019
Sino Biopharmaceutical Announces 2019 Third Quarterly Results
Thursday, August 29, 2019
Sino Biopharmaceutical Announces 2019 Interim Results
Wednesday, May 22, 2019
Sino Biopharmaceutical Announces 2019 First Quarterly Results
Monday, April 1, 2019
Sino Biopharmaceutical's 2018 Annual Results Reaches New Height
Monday, November 26, 2018
Sino Biopharmaceutical Announces 2018 Third Quarterly Results

Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: